Quantcast
Home / Practice Areas / Personal Injury and Tort / Ruling may save suits against generic drug makers

Ruling may save suits against generic drug makers

Since last year, when generic drug makers won a victory on the issue of federal preemption before the U.S. Supreme Court, lower courts have been dismissing cases against generic drug makers left and right. But last week a federal appeals court issued a ruling that gives plaintiffs a long-awaited opening in those suits.